Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.
DWS Health and Wellness S SCHLX
- NAV / 1-Day Return 44.75 / +0.13 %
- Total Assets 295.3 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.060%
- Distribution Fee Level Average
- Share Class Type No Load
- Category Health
- Investment Style Large Blend
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 0.00
- Turnover 1%
USD | NAV as of Oct 04, 2024 | 1-Day Return as of Oct 04, 2024, 10:29 PM GMT+0
Morningstar’s Analysis SCHLX
Will SCHLX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 50.7
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Eli Lilly and Co | 12.41 | 38.4 Mil | Healthcare |
UnitedHealth Group Inc | 9.71 | 30.1 Mil | Healthcare |
Merck & Co Inc | 4.05 | 12.5 Mil | Healthcare |
Novo Nordisk AS ADR | 3.94 | 12.2 Mil | Healthcare |
Boston Scientific Corp | 3.91 | 12.1 Mil | Healthcare |
Thermo Fisher Scientific Inc | 3.76 | 11.6 Mil | Healthcare |
Johnson & Johnson | 3.64 | 11.3 Mil | Healthcare |
AbbVie Inc | 3.49 | 10.8 Mil | Healthcare |
Intuitive Surgical Inc | 2.99 | 9.2 Mil | Healthcare |
AstraZeneca PLC ADR | 2.77 | 8.6 Mil | Healthcare |